Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-02

Clinical Trial Update: Shortened Regimen for Drug-susceptible TB in Children [Phase 3]

View source ↗

Summary

A Phase 3 trial in children is testing a shortened regimen for drug-susceptible tuberculosis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Johns Hopkins University | Conditions: Tuberculosis, Tuberculosis, Pulmonary | Phase 3 | Status: RECRUITING